181 related articles for article (PubMed ID: 16081688)
1. MN1-TEL myeloid oncoprotein expressed in multipotent progenitors perturbs both myeloid and lymphoid growth and causes T-lymphoid tumors in mice.
Kawagoe H; Grosveld GC
Blood; 2005 Dec; 106(13):4278-86. PubMed ID: 16081688
[TBL] [Abstract][Full Text] [Related]
2. Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9.
Kawagoe H; Grosveld GC
Blood; 2005 Dec; 106(13):4269-77. PubMed ID: 16105979
[TBL] [Abstract][Full Text] [Related]
3. The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity.
Buijs A; van Rompaey L; Molijn AC; Davis JN; Vertegaal AC; Potter MD; Adams C; van Baal S; Zwarthoff EC; Roussel MF; Grosveld GC
Mol Cell Biol; 2000 Dec; 20(24):9281-93. PubMed ID: 11094079
[TBL] [Abstract][Full Text] [Related]
4. MN1-TEL, the product of the t(12;22) in human myeloid leukemia, immortalizes murine myeloid cells and causes myeloid malignancy in mice.
Carella C; Bonten J; Rehg J; Grosveld GC
Leukemia; 2006 Sep; 20(9):1582-92. PubMed ID: 16810199
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a novel human myeloid leukemia cell line, AMU-AML1, carrying t(12;22)(p13;q11) without chimeric MN1-TEL and with high expression of MN1.
Gotou M; Hanamura I; Nagoshi H; Wakabayashi M; Sakamoto N; Tsunekawa N; Horio T; Goto M; Mizuno S; Takahashi M; Suganuma K; Yamamoto H; Hiramatsu A; Watarai M; Shikami M; Imamura A; Mihara H; Taki T; Miwa H; Taniwaki M; Nitta M
Genes Chromosomes Cancer; 2012 Jan; 51(1):42-53. PubMed ID: 21965128
[TBL] [Abstract][Full Text] [Related]
6. Pre-TCR expression cooperates with TEL-JAK2 to transform immature thymocytes and induce T-cell leukemia.
dos Santos NR; Rickman DS; de Reynies A; Cormier F; Williame M; Blanchard C; Stern MH; Ghysdael J
Blood; 2007 May; 109(9):3972-81. PubMed ID: 17192390
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of TEL-MN1 Fusion Enhances Resistance of HL-60 Cells to Idarubicin.
Gong S; Guo M; Tang G; Yang J; Qiu H
Chemotherapy; 2018; 63(6):308-314. PubMed ID: 30840968
[TBL] [Abstract][Full Text] [Related]
8. The MN1-TEL myeloid leukemia-associated fusion protein has a dominant-negative effect on RAR-RXR-mediated transcription.
van Wely KH; Meester-Smoor MA; Janssen MJ; Aarnoudse AJ; Grosveld GC; Zwarthoff EC
Oncogene; 2007 Aug; 26(39):5733-40. PubMed ID: 17369854
[TBL] [Abstract][Full Text] [Related]
9. TEL-JAK2 transgenic mice develop T-cell leukemia.
Carron C; Cormier F; Janin A; Lacronique V; Giovannini M; Daniel MT; Bernard O; Ghysdael J
Blood; 2000 Jun; 95(12):3891-9. PubMed ID: 10845925
[TBL] [Abstract][Full Text] [Related]
10. Translocation (12;22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11.
Buijs A; Sherr S; van Baal S; van Bezouw S; van der Plas D; Geurts van Kessel A; Riegman P; Lekanne Deprez R; Zwarthoff E; Hagemeijer A
Oncogene; 1995 Apr; 10(8):1511-9. PubMed ID: 7731705
[TBL] [Abstract][Full Text] [Related]
11. High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics.
Heuser M; Beutel G; Krauter J; Döhner K; von Neuhoff N; Schlegelberger B; Ganser A
Blood; 2006 Dec; 108(12):3898-905. PubMed ID: 16912223
[TBL] [Abstract][Full Text] [Related]
12. Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice.
Tsuzuki S; Seto M; Greaves M; Enver T
Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8443-8. PubMed ID: 15155899
[TBL] [Abstract][Full Text] [Related]
13. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia.
Higuchi M; O'Brien D; Kumaravelu P; Lenny N; Yeoh EJ; Downing JR
Cancer Cell; 2002 Feb; 1(1):63-74. PubMed ID: 12086889
[TBL] [Abstract][Full Text] [Related]
14. The leukemia-associated fusion protein MN1-TEL blocks TEL-specific recognition sequences.
ter Haar WM; Meester-Smoor MA; van Wely KH; Schot CC; Janssen MJ; Geverts B; Bonten J; Grosveld GC; Houtsmuller AB; Zwarthoff EC
PLoS One; 2012; 7(9):e46085. PubMed ID: 23049943
[TBL] [Abstract][Full Text] [Related]
15. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
16. Constitutively active ABL family kinases, TEL/ABL and TEL/ARG, harbor distinct leukemogenic activities in vivo.
Yokota A; Hirai H; Shoji T; Maekawa T; Okuda K
Leukemia; 2017 Dec; 31(12):2742-2751. PubMed ID: 28386107
[TBL] [Abstract][Full Text] [Related]
17. Retroviral insertional mutagenesis identifies genes that collaborate with NUP98-HOXD13 during leukemic transformation.
Slape C; Hartung H; Lin YW; Bies J; Wolff L; Aplan PD
Cancer Res; 2007 Jun; 67(11):5148-55. PubMed ID: 17545593
[TBL] [Abstract][Full Text] [Related]
18. Mapping of MN1 sequences necessary for myeloid transformation.
Kandilci A; Surtel J; Janke L; Neale G; Terranova S; Grosveld GC
PLoS One; 2013; 8(4):e61706. PubMed ID: 23626719
[TBL] [Abstract][Full Text] [Related]
19. Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model.
Fischer M; Schwieger M; Horn S; Niebuhr B; Ford A; Roscher S; Bergholz U; Greaves M; Löhler J; Stocking C
Oncogene; 2005 Nov; 24(51):7579-91. PubMed ID: 16044150
[TBL] [Abstract][Full Text] [Related]
20. AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1.
Nishida S; Hosen N; Shirakata T; Kanato K; Yanagihara M; Nakatsuka S; Hoshida Y; Nakazawa T; Harada Y; Tatsumi N; Tsuboi A; Kawakami M; Oka Y; Oji Y; Aozasa K; Kawase I; Sugiyama H
Blood; 2006 Apr; 107(8):3303-12. PubMed ID: 16380455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
